论文部分内容阅读
乳腺癌的发病率在国内有逐年提高的趋势 ,年增长率达 3 %。晚期乳腺癌预后差 ,化疗是治疗的主要方法 ,近年来由于抗癌新药的出现 ,有效率明显提高。多西紫杉醇是新一代紫杉类化疗药物 ,具有高度的抗癌活性、确切的疗效、可以耐受的毒性反应 ,已经成为乳腺癌治疗中最重要的化疗
The incidence of breast cancer in the country has increased year by year trend, the annual growth rate of 3%. Poor prognosis of advanced breast cancer, chemotherapy is the main method of treatment, in recent years due to the emergence of new anti-cancer drugs, the effective rate was significantly improved. Docetaxel is a new generation of taxane chemotherapy drugs, with a high degree of anti-cancer activity, the exact effect, tolerable toxicity, has become the most important chemotherapy in breast cancer treatment